Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT00087139 · COMPLETED

Trial details

NCT number: NCT00087139
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2004-09-01
Primary completion: 2009-04-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.